Product Information
FLUCONAZOLE 200 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.3798 per EA under NDC 62135013330. Its NADAC has been published 187 times since Mar 8, 2023.
FDA first approved this application on Jul 29, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Chartwell RX LLCNDC
62135013330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUCONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA076665FDA Approved
7/29/2004
TE Code
AB
On Market Since
7/29/2004
Pharmacological Classes
Price Statistics
The NADAC for FLUCONAZOLE 200 MG TABLET has been published 187 times since Mar 8, 2023, and over the history we have for it it has declined 25.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3798 per EA |
|---|---|
| All-time high | $0.5225 (Apr 10, 2024) |
| All-time low | $0.3449 (Nov 20, 2024) |
| 52-week high | $0.4605 |
| 52-week low | $0.3798 |
| Median price | $0.4360 |
| Average price | $0.4359 |
| Largest weekly change | -27.8% (Nov 20, 2024) |
| Weeks tracked | 187 |
| Tracking since | Mar 8, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FLUCONAZOLE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FLUCONAZOLE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUCONAZOLE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUCONAZOLE 200 MG TABLET, manufactured by Chartwell RX LLC, is $0.3798 per EA (NDC 62135013330), effective Sep 30, 2026.
How has the price of FLUCONAZOLE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUCONAZOLE 200 MG TABLET has declined 25.1%. It has been tracked across 187 weekly CMS publications since Mar 8, 2023.
What are the highest and lowest recorded NADAC prices for FLUCONAZOLE 200 MG TABLET?
Since Mar 8, 2023, the NADAC for FLUCONAZOLE 200 MG TABLET has ranged from a low of $0.3449 (Nov 20, 2024) to a high of $0.5225 (Apr 10, 2024), with a median of $0.4360 per EA.
Are there cheaper alternatives to FLUCONAZOLE 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FLUCONAZOLE 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUCONAZOLE 200 MG TABLET?
FLUCONAZOLE 200 MG TABLET (NDC 62135013330) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.